• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Trump Calls for Letting Americans Deduct Health Premiums, Import Drugs

Article

The Republican frontrunner's plan did not say how some of its proposals would be paid for in the federal budget, and parts of it were at odds were previous statements in support of requiring coverage for pre-existing conditions.

Republican frontrunner Donald Trump released a series of healthcare proposals late Wednesday that could prove highly popular with consumers, if not the powerful interest groups that may look to fight them. The plan had few specifics, particulary how the many tax breaks Trump calls for would be funded. Its populist appeal is sure to cause discussion as the presidential contest heads toward Florida, where price sensitive seniors vote March 15, 2016.

Tax breaks and the ACA

To make healthcare affordable, Trump topped the list with a proposal to “allow Americans to fully deduct health insurance premium payments from their tax returns under the current tax system.” While the idea was offered so that “no one slips through the cracks,” there was no explanation of how this would be funded in the federal budget. This proposal comes at a time of increased cost-sharing in healthcare.

In exchange, Trump repeated his call to “completely repeal Obamacare,” and singled out the Affordable Care Act’s (ACA) individual mandate for special scorn.

However, in the past Trump has signaled support for not allowing insurers to deny coverage for those with pre-existing conditions, so it is unclear how this would be addressed. He also makes no mention of a popular ACA mandate that allows young adults to stay on parents’ plans through age 26. Most experts believe that no matter what the fate of Obamacare, this piece will remain.

Repealing the ACA and offering tax breaks to ensure healthcare affordability would eliminate the reporting requirements that have come with the law, according to Dave Fried, president of TriCore, a Robbinsville, New Jersey-based firm that provides payroll, human resources, and health care benefits management services for employers in multiple states. Fried has also been Robbinsville’s mayor for more than a decade and is involved in health benefits for the town’s union and non-union workers. A Republican, Fried has not endorsed any candidate in 2016 presidential contest.

“The ACA has cost a small fortune in reporting, and it’s a tremendous amount of work for employers. We even have to report on employees who don’t work for us,” Fried said in an interview with The American Journal of Managed Care. “This causes more work and more costs, and doesn’t actually provide any coverage.”

In his opinion, the combined proposal including the tax deduction would encourage employers to contribute more to health savings accounts (HSAs, see below) or provide more funding for healthcare.

Importing drugs

Trump said he wanted to “remove the barriers to entry into free markets for drug providers that offer safe, reliable, and cheaper products.” Any proposal for importing drugs will be fiercely opposed by the pharmaceutical industry and its allies in Congress—and could create even more headaches for his new ally, New Jersey Governor Chris Christie, whose state is home to several leading drug manufacturers.

But a Trump health plan with ideas for controlling drug prices is not a surprise, since he has been on record saying that “the drug companies” are the reason that Medicare has not been able to negotiate discounts on the order seen in the Veterans Administration. As a reader of polls, Trump is no doubt aware that the Kaiser Family Foundation and others have found that lopsided majorities of consumers across the political spectrum find high drug prices to be a major problem, and that the drug companies are at fault.

On Friday, a spokeswoman for the Pharmaceutical Research and Manufacturers Association (PhRMA), said importing drugs that had not passed muster with FDA could pose a threat to patient safety. "Under both Democratic and Republican administrations, the FDA has stated it cannot assure the safety of imported medicines from foreign countries and they would present a risk to public health," said PhRMA's Holly Campbell. "The competitive biopharmaceutical marketplace for medicines in the United States works to control costs and encourages the development of new treatments and cures for patients."

Campbell said that low-cost generic drugs comprise 90% of the drugs prescribed to Americans, typically at lower prices than drugs from overseas. However, a widely read report just released by AARP found that for seniors, at least, brand name drugs account for most expenditures (64.1%), even though generics account for more actual prescriptions (69.4%).

Medicaid block grants

Calling for giving states block grants to spent on healthcare for the poor, and allowing them to spend funds “without federal overhead,” has long been an item on conservative wish lists. Opponents of this concept have had concerns whether women’s health services would be adequately funded, or whether certain high-cost items for the very poor and vulnerable would receive adequate funding.

Healthcare savings accounts (HSAs)

This is not a new idea, but one that Republicans believe needs more emphasis. Trump’s plan calls for HSA contributions to be tax-exempt, permitted to accumulate, and passed on to heirs, something critics quickly noted is allowed already. Trump’s website claims that, “These plans would be particularly attractive to young people who are healthy and can afford high-deductible insurance plans.” However, prior to ACA implementation, young adults had the highest uninsured rates of any demographic. Writing for Forbes, tax consultant Ryan Ellis asked whether Trump wanted to require everyone to have an HSA, not just those in high-deductible health plans.

Price transparency

The plan calls for transparency from all providers, especially doctors, clinics, and hospitals. Fried said issues of transparency and lack of consumer awareness about the cost of care are why he likes proposal, as well as HSAs. When consumers are only responsible for a co-pay, they don’t take time to shop for the most affordable solution, he said. “A surgery center can be 50% less expensive than going to a hospital. A small procedure could be $50,000 in a hospital, compared with $25,000 in a surgery center,” Fried said. “The difference is an entire year’s worth of premium.”

Selling insurance “across state lines"

Since the first GOP debate, Trump has mentioned this repeatedly without much detail. Today, his plan stated, “any vendor ought to be able to offer insurance in any state.” Right now, the national system of state-based regulation requires each state to admit an insurer, and for rates to be set on a state-by-state basis. Each company’s financial health is regulated in the state where it is based, or domiciled. Critics of this system say it is cumbersome, expensive, and does not allow large employers to take advantage of their size to get low rates. Advocates of the current system say scrapping it would lead to a “race to the bottom,” with large employers seeking insurers based in states with the lightest regulations.

Trump’s idea is not actually new. As proposed mergers between managed care giants reduce competition in many markets, some believe an “optional federal charter” would increase competition perhaps attract new entrants, such as property-casualty carriers who already operate nationwide. “Right now in New Jersey, we only have about 5 real choices,” Fried said. In Robbinsville, for example, the town’s health care losses were reduced, so as mayor Fried was hoping lower rates for 2016. But the rate came in flat. “No one else even chose to bid,” he said. “If barriers were open, I would have gone out of state to try to get a quote.”

At press time, there was no comment from America’s Health Insurance Plans (AHIP).

Related Videos
Dr Sophia Humphreys
Robert Zimmerman, MD
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Ryan Stice, PharmD
Raajit Rampal, MD, PhD, screenshot
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.